PE20061435A1 - Derivados de alfa-aminoacidos como ligandos del receptor alfa-2-delta - Google Patents
Derivados de alfa-aminoacidos como ligandos del receptor alfa-2-deltaInfo
- Publication number
- PE20061435A1 PE20061435A1 PE2006000431A PE2006000431A PE20061435A1 PE 20061435 A1 PE20061435 A1 PE 20061435A1 PE 2006000431 A PE2006000431 A PE 2006000431A PE 2006000431 A PE2006000431 A PE 2006000431A PE 20061435 A1 PE20061435 A1 PE 20061435A1
- Authority
- PE
- Peru
- Prior art keywords
- alpha
- amino
- ligands
- alkyl
- acid
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title abstract 2
- 150000001371 alpha-amino acids Chemical class 0.000 title 1
- 235000008206 alpha-amino acids Nutrition 0.000 title 1
- -1 INDANYL Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- WDAMHXABMOPUPC-VIFPVBQESA-N (2s)-2-amino-4-ethyl-2-methylhexanoic acid Chemical compound CCC(CC)C[C@](C)(N)C(O)=O WDAMHXABMOPUPC-VIFPVBQESA-N 0.000 abstract 1
- 108090000312 Calcium Channels Proteins 0.000 abstract 1
- 102000003922 Calcium Channels Human genes 0.000 abstract 1
- 208000001640 Fibromyalgia Diseases 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67602505P | 2005-04-28 | 2005-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061435A1 true PE20061435A1 (es) | 2007-02-03 |
Family
ID=36677128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000431A PE20061435A1 (es) | 2005-04-28 | 2006-04-25 | Derivados de alfa-aminoacidos como ligandos del receptor alfa-2-delta |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7612226B2 (enExample) |
| EP (1) | EP1879567A1 (enExample) |
| JP (2) | JP4173909B1 (enExample) |
| KR (1) | KR100925900B1 (enExample) |
| CN (1) | CN101166524B (enExample) |
| AP (1) | AP2007004161A0 (enExample) |
| AR (1) | AR054441A1 (enExample) |
| AU (1) | AU2006238933B2 (enExample) |
| BR (1) | BRPI0609879A2 (enExample) |
| CA (1) | CA2606353C (enExample) |
| CR (1) | CR9472A (enExample) |
| DO (1) | DOP2006000095A (enExample) |
| EA (1) | EA200701852A1 (enExample) |
| GT (1) | GT200600178A (enExample) |
| IL (1) | IL185790A0 (enExample) |
| MA (1) | MA29408B1 (enExample) |
| MX (1) | MX2007010978A (enExample) |
| NL (1) | NL1031705C2 (enExample) |
| NO (1) | NO20076000L (enExample) |
| PE (1) | PE20061435A1 (enExample) |
| SV (1) | SV2008002512A (enExample) |
| TN (1) | TNSN07400A1 (enExample) |
| TW (1) | TW200719889A (enExample) |
| UY (1) | UY29498A1 (enExample) |
| WO (1) | WO2006114707A1 (enExample) |
| ZA (1) | ZA200707678B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0934061B3 (en) | 1996-07-24 | 2015-01-21 | Warner-Lambert Company LLC | Isobutylgaba and its derivatives for the treatment of pain |
| EP1879567A1 (en) * | 2005-04-28 | 2008-01-23 | Pfizer Limited | Amino acid derivatives |
| WO2007057767A2 (en) * | 2005-11-17 | 2007-05-24 | Pfizer Limited | Amino acid derivatives |
| WO2008031221A1 (en) * | 2006-09-12 | 2008-03-20 | Cephalin Pharmaceuticals Inc. | Isovaline for treatment of pain |
| CN101195583B (zh) * | 2006-12-04 | 2012-07-04 | 四川抗菌素工业研究所有限公司 | 一种光学纯米那普仑及其盐的制备方法 |
| CN102143943B (zh) * | 2008-09-09 | 2014-03-12 | 弗·哈夫曼-拉罗切有限公司 | 酰基磺酰胺的多晶型物 |
| JP2012176902A (ja) * | 2011-02-25 | 2012-09-13 | Tosoh F-Tech Inc | 新規な光学活性含フッ素化合物、その製造方法及びそれを用いた光学活性３，３，３−トリフルオロアラニンの製造方法 |
| AT514349B1 (de) * | 2013-06-12 | 2018-05-15 | Red Bull Gmbh | Alpha-alkylierte Aminosäuren (AAAAs) |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB504209A (en) | 1937-12-14 | 1939-04-21 | Pirelli General Cable Works | Improvements in or relating to electric cables |
| BR6239521D0 (pt) * | 1961-08-09 | 1973-06-14 | Merck & Co Inc | Processo de preparacao de novos amino acidos |
| FR2586562B1 (fr) | 1985-09-02 | 1989-03-10 | Inst Nat Sante Rech Med | Composition pharmaceutique contenant de l'a-methylhistamine |
| DE3811256A1 (de) | 1988-04-02 | 1989-10-19 | Hoechst Ag | (alpha)-trifluormethylaminosaeure-derivate, verfahren zur herstellung von (alpha)-trifluormethylaminosaeure-derivaten und ihre verwendung als arzneimittel |
| WO1991001724A1 (en) | 1989-07-27 | 1991-02-21 | G.D. Searle & Co. | Renal-selective prodrugs for the treatment of hypertension |
| FR2681067B1 (fr) * | 1991-09-10 | 1993-12-17 | Elf Sanofi | Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant. |
| JPH042899A (ja) | 1990-04-16 | 1992-01-07 | Arakawa Chem Ind Co Ltd | 紙用サイズ剤および該サイズ剤を用いる紙サイジング方法 |
| FR2661909B1 (fr) | 1990-05-09 | 1997-08-14 | Inst Nat Sante Rech Med | Nouveaux composes agonistes du recepteur h3 de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation. |
| JPH051002A (ja) | 1991-02-15 | 1993-01-08 | Nikko Kyodo Co Ltd | α−アミノ酸の製造方法 |
| CA2068038A1 (en) | 1991-05-08 | 1992-11-09 | Christopher Yee | Enzymatic resolution of .alpha.-tertiary carboxylic acid esters |
| US5993775A (en) | 1991-11-27 | 1999-11-30 | Diatide, Inc. | Radioactively labeled peptides comprising a single thiol moiety |
| GB9200210D0 (en) | 1992-01-07 | 1992-02-26 | British Bio Technology | Compounds |
| EP0667773A4 (en) | 1992-10-14 | 1996-09-25 | Merck & Co Inc | FIBRINOGEN RECEPTOR ANTAGONISTS. |
| US5362747A (en) | 1992-11-25 | 1994-11-08 | Abbott Laboratories | 2-nitroaryl and 2-cyanoaryl compounds as regulators of nitric oxide synthase |
| GB9325360D0 (en) | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
| GB9325368D0 (en) | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
| IS4261A (is) | 1994-02-21 | 1995-08-22 | Astra Aktiebolag | Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra |
| DE19533617A1 (de) | 1995-09-11 | 1997-03-13 | Degussa | Neues Verfahren zur Herstellung von optisch aktiven alpha-Aminosäuren und alpha-Aminosäure-Derivaten |
| DK0780386T3 (da) | 1995-12-20 | 2003-02-03 | Hoffmann La Roche | Matrixmetalloproteaseinhibitorer |
| WO1998014208A1 (en) | 1996-09-30 | 1998-04-09 | President And Fellows Of Harvard College | Reactive ligands and covalent ligand-protein complexes |
| US5962523A (en) | 1996-10-25 | 1999-10-05 | Discovery Laboratories, Inc. | Methods of using butyric acid derivatives to protect against hair loss |
| JPH10333511A (ja) | 1997-05-30 | 1998-12-18 | Ricoh Co Ltd | 画像除去促進液、該画像除去促進液を用いた被記録材の再生方法及び再生装置 |
| JP4205191B2 (ja) | 1997-12-26 | 2009-01-07 | ダイセル化学工業株式会社 | α−アミノニトリル誘導体及びα−アミノ酸の製造方法 |
| CN1235559C (zh) | 1998-03-11 | 2006-01-11 | 株式会社创研 | 皮肤水分保持能力的改善剂 |
| EP1071655A1 (en) * | 1998-04-17 | 2001-01-31 | Kenneth Curry | Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| KR20010086126A (ko) | 1998-12-18 | 2001-09-07 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | 융합된 1,2,4-티아디아진 유도체 및 그의 제법 및 용도 |
| EP1140784A2 (en) | 1998-12-22 | 2001-10-10 | Neurosearch A/S | Ion channel modulating agents |
| FR2788271B1 (fr) | 1999-01-07 | 2001-02-09 | Rhone Poulenc Agrochimie | Nouveau procede de preparation d'aminoacides chiraux |
| JP2002535302A (ja) | 1999-01-22 | 2002-10-22 | ファーマコア，インコーポレイテッド | 化学式１の化合物およびその誘導体の合成方法 |
| CA2359030A1 (en) | 1999-01-28 | 2000-08-03 | Chugai Seiyaku Kabushiki Kaisha | Substituted phenethylamine derivatives |
| FR2791982B1 (fr) | 1999-04-06 | 2002-12-27 | Inst Nat Sante Rech Med | Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques. |
| WO2001009117A1 (en) | 1999-07-29 | 2001-02-08 | Allellix Neuroscience Inc. | Tricyclic compounds as glycine transport inhibitors |
| FR2796943A1 (fr) | 1999-07-30 | 2001-02-02 | Aventis Pharma Sa | Derives de benzoxazinnes, leur procede de preparation et leur utilisation en therapeutique |
| AU5449699A (en) | 1999-09-07 | 2001-04-10 | Kabushiki Kaisha Soken | Skin normalizing agents |
| JP4728548B2 (ja) | 1999-09-07 | 2011-07-20 | 三菱レイヨン株式会社 | 光学活性アミノアルコールの製造方法 |
| JP2001081013A (ja) | 1999-09-10 | 2001-03-27 | Soken Kk | 毛髪健全化剤 |
| US7300775B2 (en) | 1999-12-29 | 2007-11-27 | Verenium Corporation | Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents |
| US6656958B2 (en) | 2000-02-02 | 2003-12-02 | Abbott Laboratories | Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| DE10121028A1 (de) | 2000-05-05 | 2002-01-31 | Basf Ag | Verfahren zur Herstellung von Aldehyden |
| DE10121026A1 (de) | 2000-05-05 | 2002-02-07 | Basf Ag | Verfahren zur Herstellung von Aldehyden |
| US6949658B2 (en) | 2000-05-18 | 2005-09-27 | Mitsubishi Rayon Co., Ltd. | Process for producing optically active α-amino acid and optically active α-amino acid amide |
| WO2003011799A1 (en) | 2000-07-31 | 2003-02-13 | Brandeis University | Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids |
| DE10048715A1 (de) * | 2000-09-30 | 2004-05-19 | Grünenthal GmbH | Verwendung von Aminosäure zur Behandlung von Schmerz |
| AUPR406901A0 (en) | 2001-03-29 | 2001-04-26 | La Trobe University | Insecticide and method of controlling insects |
| JP4715058B2 (ja) | 2001-08-02 | 2011-07-06 | Ｊｓｒ株式会社 | 感放射性樹脂組成物 |
| JP2003221328A (ja) | 2002-01-29 | 2003-08-05 | Soken Kk | 皮膚健全化剤 |
| US6903220B2 (en) | 2002-05-15 | 2005-06-07 | Genzyme Corporation | Synthesis of chiral 2-alkyl amino acids |
| JP2006504664A (ja) | 2002-08-01 | 2006-02-09 | ビーエーエスエフ アクチェンゲゼルシャフト | 農薬フルオロアルケン誘導体 |
| US20060025471A1 (en) * | 2002-09-13 | 2006-02-02 | Kenneth Curry | Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors |
| AU2003289242A1 (en) | 2003-01-10 | 2004-08-10 | Kaneka Corporation | PROCESS FOR PRODUCING OPTICALLY ACTIVE Alpha-METHYLCYSTEINE DERIVATIVE |
| JP2005060311A (ja) | 2003-08-13 | 2005-03-10 | Mochida Pharmaceut Co Ltd | Ｎ−（ベンゾイル）アミノ酸誘導体を有効成分とするニューロパシー性疼痛治療剤 |
| GB0322140D0 (en) * | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
| WO2005044780A1 (ja) | 2003-11-10 | 2005-05-19 | Kyorin Pharmaceutical Co., Ltd. | アミノカルボン酸誘導体とその付加塩及びｓ１ｐ受容体調節剤 |
| JP2007522118A (ja) * | 2004-01-30 | 2007-08-09 | ペプリン バイオリピッズ ピーティーワイ エルティーディー | 治療用分子および担体分子 |
| GB0405289D0 (en) | 2004-03-09 | 2004-04-21 | Novartis Ag | Organic compounds |
| TW200642687A (en) * | 2005-03-01 | 2006-12-16 | Pfizer Ltd | Combinations comprising α-2-δ ligands |
| EP1855686A1 (en) | 2005-03-01 | 2007-11-21 | Pfizer Limited | Use of pde7 inhibitors for the treatment of neuropathic pain |
| EA200701745A1 (ru) * | 2005-03-17 | 2008-06-30 | Пфайзер, Инк. | Циклопропанкарбоксамидные производные |
| EP1879567A1 (en) * | 2005-04-28 | 2008-01-23 | Pfizer Limited | Amino acid derivatives |
| WO2007063391A2 (en) * | 2005-12-02 | 2007-06-07 | Pfizer Limited | Spirocyclic quinazoline derivatives as pde7 inhibitors |
-
2006
- 2006-04-19 EP EP06727559A patent/EP1879567A1/en not_active Withdrawn
- 2006-04-19 AU AU2006238933A patent/AU2006238933B2/en not_active Ceased
- 2006-04-19 EA EA200701852A patent/EA200701852A1/ru unknown
- 2006-04-19 CA CA2606353A patent/CA2606353C/en not_active Expired - Fee Related
- 2006-04-19 CN CN2006800141982A patent/CN101166524B/zh not_active Expired - Fee Related
- 2006-04-19 WO PCT/IB2006/001086 patent/WO2006114707A1/en not_active Ceased
- 2006-04-19 AP AP2007004161A patent/AP2007004161A0/xx unknown
- 2006-04-19 JP JP2008508341A patent/JP4173909B1/ja not_active Expired - Fee Related
- 2006-04-19 MX MX2007010978A patent/MX2007010978A/es active IP Right Grant
- 2006-04-19 KR KR1020077024860A patent/KR100925900B1/ko not_active Expired - Fee Related
- 2006-04-19 BR BRPI0609879-7A patent/BRPI0609879A2/pt not_active Application Discontinuation
- 2006-04-25 PE PE2006000431A patent/PE20061435A1/es not_active Application Discontinuation
- 2006-04-26 DO DO2006000095A patent/DOP2006000095A/es unknown
- 2006-04-26 AR ARP060101665A patent/AR054441A1/es not_active Application Discontinuation
- 2006-04-26 UY UY29498A patent/UY29498A1/es not_active Application Discontinuation
- 2006-04-27 NL NL1031705A patent/NL1031705C2/nl not_active IP Right Cessation
- 2006-04-27 GT GT200600178A patent/GT200600178A/es unknown
- 2006-04-27 TW TW095115092A patent/TW200719889A/zh unknown
- 2006-04-28 US US11/414,422 patent/US7612226B2/en not_active Expired - Fee Related
- 2006-04-28 SV SV2006002512A patent/SV2008002512A/es not_active Application Discontinuation
-
2007
- 2007-09-06 IL IL185790A patent/IL185790A0/en unknown
- 2007-09-06 ZA ZA200707678A patent/ZA200707678B/xx unknown
- 2007-10-25 CR CR9472A patent/CR9472A/es unknown
- 2007-10-26 TN TNP2007000400A patent/TNSN07400A1/fr unknown
- 2007-10-26 MA MA30323A patent/MA29408B1/fr unknown
- 2007-11-21 NO NO20076000A patent/NO20076000L/no not_active Application Discontinuation
-
2008
- 2008-07-02 JP JP2008173198A patent/JP2009040767A/ja not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20190914A1 (es) | Combinacion farmaceutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepileptico | |
| AR047972A1 (es) | Derivado de bencimidazol, proceso de obtencion y composiciones farmaceuticas. | |
| PE20021014A1 (es) | Derivados de glutaramida sustituida con n-fenpropilciclopentilo como inhibidores de nep para fsad | |
| ES2523732T3 (es) | Control de composiciones de copolímeros | |
| BRPI0518589A2 (pt) | bactÉria corineforme, e, mÉtodo para produzir um l-aminoÁcido | |
| CY1117449T1 (el) | Φαινυλιουχα ν-ακυλο παραγωγα αμινων και αμινοξεων, μεθοδοι για την παραγωγη αυτων, μια φαρμακευτικη συνθεση και η χρηση αυτων | |
| ATE415387T1 (de) | Verfahren zur herstellung von benzonitrilen und benzimidosäure-derivaten | |
| EA201001766A1 (ru) | Новые[f-18]-меченые производные l-глутаминовой кислоты и l-глутамина (i), их применение, а также способ их получения | |
| TW200745097A (en) | 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors | |
| DK1740694T3 (da) | L-tryptofan-producerende bakterie og fremgangsmåde til produktion af L-tryptofan | |
| EA200900732A1 (ru) | Кристаллическая калиевая соль аналогов липоксина а | |
| EA200701810A1 (ru) | Производное изоксазолина и новый способ его получения | |
| NZ600910A (en) | Process for the preparation of chelated compounds | |
| AR048973A1 (es) | (4-metoxi-7-morfolin-4-il-benzotiazol-2-il)amida del acido 4-hidroxi-4-metil-piperidin-1-carboxilico. proceso de preparacion y composiciones farmaceuticas | |
| ES2729198T3 (es) | Preparación de derivados de pirrolidina | |
| BR0206730A (pt) | Processo para preparar uma composição de valproato de sódio não-higroscópica, composição farmacêutica não-higroscópia e seu uso | |
| RU2014118122A (ru) | Производное бутилфталида, способ его получения и применение | |
| BRPI0814115B8 (pt) | composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto | |
| EA201070603A1 (ru) | Лекарственное средство, активное в отношении невропатической боли | |
| PE20100139A1 (es) | Nuevas n-(2-amino-fenil)-acrilamidas | |
| CY1111730T1 (el) | Διαδικασια για την παρασκευη γκαμπαπεντινης | |
| IL190399A0 (en) | Novel method for preparing quaternary acid and ammonium salts | |
| AR067788A1 (es) | Proceso para la preparacion de un polipeptido para su uso farmaceutico | |
| RU2009103818A (ru) | Водная лекарственная композиция 4-[(4-карбоксибутил)-{2-[(4-фенетилбензил)окси)-фенетил}амино)метил)-бензойной кислоты | |
| RU2013108755A (ru) | Терапевтическое средство или профилактическое средство для нейропатической боли |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |